Reuters- Japanese Pharma Co. Yamanouchi to Double Genomics Spending in Five Years | GenomeWeb

NEW YORK, April 24 – Yamanouchi pharmaceuticals, Japan's third-largest drug maker,  plans to spend 50 billion yen, or $411.8 million, on genomics in the next five years, Reuters reported from Japan on Tuesday.

This investment doubles the company’s recent genomics spending level of four to 5 billion yen in the past several years.  

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.